UK Study Finds Pulmonary Rehab for COPD Underutilized – MedicalResearch.com (blog)


UK Study Finds Pulmonary Rehab for COPD Underutilized
MedicalResearch.com (blog)
Response: We were commissioned by the Chartered Society of Physiotherapy in the UK to undertake a piece of work to show the value of pulmonary rehabilitation in reducing exacerbations in COPD patients so that they could create a web based tool that ...

FDA clears first nebulized LAMA inhaler for COPD – Pharmacy Today, American Pharmacists Association, pharmacist.com


FDA clears first nebulized LAMA inhaler for COPD
Pharmacy Today, American Pharmacists Association, pharmacist.com
FDA has approved glycopyrrolate inhalation solution 25 mcg twice daily (Lonhala Magnair—Sunovion Pharmaceuticals) for maintenance treatment of airflow obstruction in adults with chronic obstructive pulmonary disease (COPD). It is the first nebulized ...

US and China Asthma and COPD Drugs Market Is Anticipated to Be Worth US $18.7 Bn over Forecast 2016-2024 – Digital Journal


satPRnews

US and China Asthma and COPD Drugs Market Is Anticipated to Be Worth US $18.7 Bn over Forecast 2016-2024
Digital Journal
Albany, NY -- (SBWIRE) -- 12/14/2017 -- Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the ...
Inhalation Spray-Based Drugs Market: Industry Growth Report and Forecast 2017 to 2025MilTech

all 3 news articles »